FGF23 and breast cancer: Physiological factors include those influencing atherosclerosis and bone remodeling, such as lipid oxidation, osteoprotegerin, sclerosing protein, metastatic breast cancer cells and fibroblast growth factor 23 (FGF-23) [10].